Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Other
Tripelennamine is a first-generation ethylenediamine antihistamine used to treat allergic rhinitis, urticaria, and pruritus. It works by competitively blocking H1 receptors to alleviate allergy symptoms.
Name
Tripelennamine
Raw Name
TRIPELENNAMINE
Category
Other
Drug Count
3
Variant Count
3
Last Verified
February 17, 2026
RxCUI
2727223, 2711712
UNII
3C5ORO99TY
About Tripelennamine
Tripelennamine is a first-generation ethylenediamine antihistamine used to treat allergic rhinitis, urticaria, and pruritus. It works by competitively blocking H1 receptors to alleviate allergy symptoms.
Detailed information about Tripelennamine
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Tripelennamine.
In the context of modern medicine in 2026, Tripelennamine is categorized as a H1-receptor antagonist. It is primarily indicated for the symptomatic relief of various allergic conditions, including perennial and seasonal allergic rhinitis (hay fever), vasomotor rhinitis, and allergic conjunctivitis. Furthermore, it is highly effective in treating dermatological manifestations of allergies, such as urticaria (hives), angioedema (swelling under the skin), and various forms of pruritus (itching) associated with insect bites or contact dermatitis. Because it is a first-generation agent, it crosses the blood-brain barrier more readily than modern alternatives, which accounts for its significant sedative properties.
To understand how Tripelennamine works, one must first understand the role of histamine in the human body. Histamine is a potent chemical mediator released by mast cells and basophils during an allergic reaction. When an allergen (such as pollen or pet dander) enters the body of a sensitized individual, it triggers the release of histamine, which then binds to specific H1 receptors located throughout the body, including the skin, blood vessels, and respiratory tract. This binding causes the typical symptoms of an allergy: itching, swelling, redness, and increased mucus production.
Tripelennamine acts as a competitive antagonist at these H1 receptor sites. This means that the drug 'competes' with histamine for the same receptor 'docking stations.' By occupying these receptors, Tripelennamine prevents histamine from binding and initiating the inflammatory cascade. It is important to note that Tripelennamine does not prevent the actual release of histamine; rather, it neutralizes the effect of histamine that has already been released. At the molecular level, it also possesses significant anticholinergic activity, which helps dry up nasal secretions, and mild local anesthetic properties, which can help soothe itchy skin when applied topically or taken systemically.
The pharmacokinetic profile of Tripelennamine describes how the body processes the medication from the moment of ingestion to its final excretion. Understanding these parameters is crucial for determining the frequency of dosing and predicting potential drug interactions.
Tripelennamine is FDA-approved for several specific indications, all related to the management of histamine-mediated conditions.
Off-label, healthcare providers have occasionally used Tripelennamine for its sedative properties in patients with insomnia related to itchy skin conditions, though this is less common in 2026 due to the availability of more targeted sleep aids.
Tripelennamine has historically been available in several formulations to accommodate different patient needs, though availability may vary by region:
> Important: Only your healthcare provider can determine if Tripelennamine is right for your specific condition. This medication is often found in older generic formulations, and its use should be strictly supervised by a medical professional, especially in elderly or pediatric populations.
For the treatment of general allergic symptoms, allergic rhinitis, or urticaria, the standard adult dosage of Tripelennamine Hydrochloride is typically 25 mg to 50 mg taken orally every 4 to 6 hours.
Tripelennamine must be dosed with extreme caution in children. The pediatric dose is usually calculated based on the child's body weight.
Because the metabolites of Tripelennamine are excreted by the kidneys, patients with significant renal impairment (kidney disease) may require lower doses or extended dosing intervals to prevent drug accumulation and toxicity. Healthcare providers will typically monitor the Glomerular Filtration Rate (GFR) before prescribing.
As the liver is the primary site of metabolism for Tripelennamine, patients with cirrhosis or hepatitis must be treated with caution. A reduction in the starting dose is often necessary, as the body's ability to clear the drug is diminished, leading to prolonged sedation and increased side effect risks.
Patients over the age of 65 are significantly more sensitive to the effects of Tripelennamine. The American Geriatrics Society (Beers Criteria) generally advises against the use of first-generation antihistamines in the elderly due to the high risk of falls, confusion, and urinary retention. If used, the lowest possible dose should be initiated.
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and return to your regular routine. Do not double the dose to catch up, as this significantly increases the risk of severe sedation or anticholinergic toxicity.
An overdose of Tripelennamine can be life-threatening. Signs of overdose include:
In the event of a suspected overdose, contact emergency services (911) or a poison control center immediately. Treatment usually involves supportive care, gastric lavage, and sometimes the administration of physostigmine for severe anticholinergic symptoms.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop the medication without medical guidance, as sudden changes can affect the management of your allergic condition.
The most frequently reported side effect of Tripelennamine is central nervous system depression, specifically drowsiness and sedation. For many patients, this can feel like a 'brain fog' or a significant decrease in alertness. This effect is most pronounced during the first few days of treatment and may diminish as the body adjusts to the medication. Other common effects include:
These effects occur in a smaller percentage of the population but are still clinically significant:
Rare but documented side effects include:
> Warning: Stop taking Tripelennamine and call your doctor immediately if you experience any of the following:
While Tripelennamine is generally intended for short-term use, prolonged administration can lead to:
As of 2026, there are no formal FDA Black Box Warnings for Tripelennamine. However, it carries significant 'Precautions' regarding its use in pediatric populations and its potential for abuse. Historically, Tripelennamine was used illicitly in combination with the opioid pentazocine (a combination known as 'T's and Blues'), which led to severe pulmonary complications and death. Patients should be aware of this history and use the medication only as prescribed.
Report any unusual symptoms or persistent side effects to your healthcare provider to ensure your treatment plan remains safe and effective.
Tripelennamine is a potent medication that affects the central nervous system and the autonomic nervous system. Patients must be aware that the primary safety concern is impaired mental alertness. Because this drug causes significant drowsiness, it can dangerously impair your ability to perform tasks requiring focus. Furthermore, Tripelennamine has 'anticholinergic' effects, meaning it blocks the action of acetylcholine, a neurotransmitter that controls many involuntary body functions like heart rate, digestion, and urination.
There are currently no FDA black box warnings for Tripelennamine. However, the lack of a black box warning does not imply the drug is without risk. It is a 'high-risk' medication for certain populations, particularly the elderly and very young children.
For short-term use, intensive lab monitoring is usually not required. However, for those on extended therapy, healthcare providers may order:
Do not drive, operate heavy machinery, or engage in hazardous activities until you know how Tripelennamine affects you. The impairment caused by first-generation antihistamines can be equivalent to legal alcohol intoxication, even if you do not 'feel' excessively tired.
Alcohol must be strictly avoided while taking Tripelennamine. Alcohol significantly increases the sedative effects of the drug, which can lead to dangerous levels of CNS depression, loss of consciousness, and an increased risk of accidents.
While Tripelennamine does not typically cause a 'withdrawal syndrome' in the traditional sense, stopping it abruptly after long-term use may cause a 'rebound' effect where allergy symptoms return with greater intensity. If you have been taking it daily for several weeks, discuss a tapering schedule with your doctor.
> Important: Discuss all your medical conditions, especially any history of glaucoma, stomach ulcers, or urinary issues, with your healthcare provider before starting Tripelennamine.
For each major interaction, the mechanism typically involves either pharmacodynamic synergy (two drugs doing the same thing to the body, like causing sleepiness) or metabolic inhibition (one drug stopping the liver from breaking down the other). The clinical consequence is usually increased toxicity or profound sedation. The management strategy is almost always to avoid the combination or significantly reduce the dose of both agents under strict medical supervision.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter cold and flu medicines which may also contain antihistamines.
There are several conditions where the use of Tripelennamine is strictly prohibited due to the risk of severe harm or death:
These conditions require a careful risk-benefit analysis by a physician:
Patients who are allergic to Ethylenediamine (often found in industrial solvents or as a stabilizer in certain creams) are highly likely to be allergic to Tripelennamine. This is a critical piece of medical history to share with your doctor, as cross-sensitivity is a common cause of unexpected drug reactions.
> Important: Your healthcare provider will evaluate your complete medical history, including any history of breathing problems or eye disease, before prescribing Tripelennamine.
Tripelennamine is generally classified as FDA Pregnancy Category B. This means that animal reproduction studies have failed to demonstrate a risk to the fetus, but there are no adequate and well-controlled studies in pregnant women.
Tripelennamine is not recommended for use while breastfeeding. Small amounts of the drug are excreted into breast milk. Because infants are particularly sensitive to the side effects of first-generation antihistamines, they may experience excessive sleepiness, irritability, or even respiratory issues. Additionally, the anticholinergic properties of Tripelennamine can inhibit the hormone prolactin, potentially leading to a decreased milk supply.
While approved for children over the age of 6, Tripelennamine must be used with caution.
In patients over 65, Tripelennamine is considered a high-risk medication.
Patients with a GFR (Glomerular Filtration Rate) below 50 mL/min should have their dose reduced by 50%. In cases of end-stage renal disease or dialysis, Tripelennamine should be used with extreme caution, as the removal of the drug via dialysis is not well-characterized.
In patients with Child-Pugh Class B or C liver disease, the half-life of Tripelennamine can be doubled. Dosing should be initiated at the lowest possible level (e.g., 25 mg once or twice daily) with careful monitoring for signs of excessive CNS depression.
> Important: Special populations require individualized medical assessment and frequent monitoring to ensure the drug is being used safely.
Tripelennamine is a competitive H1-receptor antagonist. It works by binding to the H1 receptors on effector cells, thereby preventing histamine from attaching to these sites. By blocking the H1 receptor, it inhibits the physiological effects of histamine, such as vasodilation (widening of blood vessels), increased capillary permeability (which causes swelling), and the stimulation of sensory nerves (which causes itching). Unlike second-generation antihistamines, Tripelennamine has a high affinity for H1 receptors in the brain, leading to its characteristic sedative effects. It also possesses significant antimuscarinic (anticholinergic) activity, which accounts for its ability to dry up bodily secretions.
| Parameter | Value |
|---|---|
| Bioavailability | Approximately 50-70% (subject to first-pass metabolism) |
| Protein Binding | ~50-60% |
| Half-life | 3 to 4 hours |
| Tmax | 2 to 3 hours |
| Metabolism | Hepatic (N-demethylation, Glucuronidation) |
| Excretion | Renal (90% as metabolites), Fecal (<5%) |
Tripelennamine is a member of the Ethylenediamine class of first-generation antihistamines. Other drugs in this historical class include pyrilamine and antazoline. While they are effective, they are generally more sedating and have more gastrointestinal side effects than the ethanolamine class (like diphenhydramine) or the alkylamine class (like chlorpheniramine).
Medications containing this ingredient
Common questions about Tripelennamine
Tripelennamine is primarily used to relieve symptoms of various allergic conditions, such as hay fever (allergic rhinitis) and hives (urticaria). It is effective at reducing sneezing, a runny nose, and the intense itching associated with skin rashes or insect bites. Additionally, it may be used to treat allergic conjunctivitis, which causes red, itchy eyes. Healthcare providers sometimes prescribe it for dermatographism, a condition where the skin becomes inflamed after being touched or scratched. Because it is an older antihistamine, it is often chosen when a patient needs both allergy relief and a mild sedative effect to help with sleep disturbed by itching.
The most frequent side effect of Tripelennamine is significant drowsiness or sedation, which affects a large majority of users. Many people also experience 'anticholinergic' effects, such as a very dry mouth, blurred vision, and constipation. Dizziness and a feeling of being 'unsteady' on your feet are also quite common, especially in older adults. Some patients report gastrointestinal upset, including nausea or stomach pain, shortly after taking the medication. In children, the drug can sometimes cause the opposite of sedation, leading to nervousness, irritability, or trouble sleeping.
No, you should strictly avoid drinking alcohol while taking Tripelennamine. Alcohol acts as a central nervous system depressant and will significantly multiply the sedative effects of the antihistamine. This combination can lead to extreme lethargy, loss of physical coordination, and dangerously slowed breathing. Even a small amount of alcohol can make it unsafe for you to perform basic tasks or stay awake. Mixing the two also increases the risk of accidental injury, such as falls or car accidents, due to the profound impairment of judgment and motor skills.
Tripelennamine is classified as a Category B medication for pregnancy, meaning there is no clear evidence of harm in animal studies, but human data is limited. Most healthcare providers recommend avoiding its use during the first trimester unless the benefits clearly outweigh the risks. In the later stages of pregnancy, it should be used with caution as it may affect the newborn's behavior or cause irritability. If you are pregnant or planning to become pregnant, you should discuss safer, more modern antihistamine alternatives with your doctor. Always consult a medical professional before taking any medication while expecting.
Tripelennamine is absorbed relatively quickly by the body, with most patients noticing an improvement in their symptoms within 15 to 30 minutes. The medication reaches its peak concentration in the bloodstream approximately 2 to 3 hours after it is swallowed. The effects of a standard dose typically last for about 4 to 6 hours, which is why it is usually taken multiple times a day. If you are using the extended-release version, the onset is similar, but the effects are designed to last for up to 12 hours. For the best results in treating seasonal allergies, it is often most effective when taken consistently.
Yes, Tripelennamine can generally be stopped suddenly without causing dangerous withdrawal symptoms, as it is not an addictive substance like opioids. However, if you have been taking it for a long period to manage chronic allergies, you may experience a 'rebound' effect where your allergy symptoms return quickly and feel more severe than before. Some people might also experience a few days of mild restlessness or trouble sleeping if they were using the drug's sedative properties to help them rest. It is always best to consult your doctor before stopping a medication you have been using daily. They can help you transition to a different allergy treatment if needed.
If you miss a dose of Tripelennamine, you should take it as soon as you realize you have forgotten it. However, if it is nearly time for your next scheduled dose, you should skip the missed one and simply take your next dose at the regular time. Never take two doses at once to make up for a missed one, as this significantly increases the risk of toxic side effects and extreme sedation. Keeping a consistent schedule helps maintain a steady level of the medication in your blood to keep allergy symptoms under control. If you frequently forget doses, using a pill reminder app or a weekly pill box may be helpful.
Weight gain is not a commonly reported side effect of Tripelennamine, especially when used for short periods to treat acute allergy symptoms. However, some first-generation antihistamines can increase appetite in certain individuals due to their interaction with histamine receptors in the brain that regulate hunger. Additionally, the sedation caused by the drug might lead to decreased physical activity, which could indirectly contribute to weight gain over time. If you notice a significant change in your weight while taking this medication, you should discuss it with your healthcare provider. They can help determine if the drug or another factor is responsible.
Tripelennamine has many potential drug interactions, so it must be used cautiously with other medications. It should never be taken with MAO inhibitors, and it should be used very carefully with other drugs that cause sleepiness, such as sleeping pills, muscle relaxants, or narcotic pain relievers. It can also interact with other anticholinergic drugs, leading to severe dry mouth, blurred vision, or inability to urinate. Even over-the-counter cold and flu medicines may contain other antihistamines, which could lead to an accidental overdose if taken together. Always provide your doctor or pharmacist with a full list of all the supplements and medications you are currently taking.
Yes, Tripelennamine is available as a generic medication, although it is less commonly stocked in pharmacies today than newer antihistamines like cetirizine or fexofenadine. In the past, it was sold under brand names like PBZ or Pyribenzamine, but many of these brand-name versions have been discontinued in favor of generic formulations. Because it is an older drug, the generic version is usually quite affordable. If your doctor prescribes Tripelennamine, you may need to check with your pharmacist to see if they have it in stock or if they need to order it for you. It is available in several forms, including standard tablets and elixirs.